Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients
- Details
- Category: HCV Disease Progression
- Published on Tuesday, 09 June 2009 13:41
- Written by Liz Highleyman
As reported at the Digestive Disease Week (DDW 2009) annual meeting last week in Chicago, Bhavna Malik and colleagues sought to determine whether the presence of clinical risk factors for non-alcoholic fatty liver disease (NAFLD) -- i.e., obesity, type 2 diabetes, hypertriglyceridemia (elevated triglycerides), and hypertension (high blood pressure) -- in people with hepatitis C increases the risk of progression to HCC.
More Articles...
- EASL 2009: Early Treatment of Acute Hepatitis C with Pegylated Interferon Monotherapy Produces Better Results than Delayed Combination Therapy
- Long-term Maintenance Interferon Does Not Prevent Hepatocellular Carcinoma among Chronic Hepatitis C Patients in HALT-C Study
- Older Donor Liver Grafts May Be Suitable for Chronic Hepatitis C Patients Requiring Transplantation
- DDW 2008: Higher HBV DNA Levels Linked to Increased Risk of Liver Cirrhosis in People with Chronic Hepatitis B
- CROI 2008: Rapid Liver Fibrosis Progression in HIV Positive Men with Acute HCV Infection
Web Design and Development by